November 20,2007
Grassley, Baucus seek information from former drug company executive in Avandia case
WASHINGTON — Sens. Chuck Grassley and Max Baucus have asked a former drug company research executive to provide information to the Senate Committee on Finance about attempts to intimidate a prominent independent scientist who voiced concerns about drug safety.
Dr. Tadataka Yamada was formerly the head of research at GlaxoSmithKline. He now heads the Global Health Program at the Bill and Melinda Gates Foundation. Dr. John Buse was a professor of medicine at the University of North Carolina in 1999, when he expressed concerns about the diabetes drug Avandia, which is made by GlaxoSmithKline.
###
Next Article Previous Article
Recent News
- Wyden Statement on IRS Nominee Billy Long's Involvement in Tax Scams
- Wyden Opposes HHS Nominees O'Neill and Andres to be Deputy Secretary and Congressional Liaison
- Wyden Blasts Trump's Tariff War Threatening Global Supply Chains at Finance Committee Hearing
- Wyden, Cortez Masto Demand Answers From Promoters who paid IRS Nominee Billy Long to Sell Investors Fraudulent “Tribal Tax Credits”
- Wyden Statement on Trump Drug Pricing Announcement